To OTC Journal Members:
 

Don't Say You Weren't Warned; Part Deux (II)

Every year I publish somewhere in the neighborhood of 100 to 120 editions of the OTC Journal. It is my mission to be the single best and most honest source for microcap ideas you can find. I know of no other microcap resource that provides anything close to our content. Sure, we have some losers- it's an inherent part of microcap investing. However, no other newsletter tells you when you have a loser, when it's time to throw in the towel, and gives you more detailed opinionated content on an ongoing basis. Also, there is no other microcap newsletter providing a forum for ongoing dialogue and direct communication with the editor- you can do that in the OTC Journal through both the Blog and by simply emailing editor@otcjournal.com. 

Every year out of the 100 plus editions there are always a couple that stand out. So far, this year's most prophetic edition would have to go to May 21st- the edition entitled "Don't Say You Weren't Warned". I could simply republish that edition at about the same time every year. The theme- the summer doldrums are coming, and if you aren't prepared to hold your positions through the miserable, low volume, down ticking summer months, sell them and get out. I set SSLs (Suggest Stop Losses) for every followed company at that time.

When I published that edition, I had no way of knowing that oil and gold prices would skyrocket in June, and microcaps would get clobbered. Every featured stock traded below its SSL with the exception of my best current idea- Commerce Planet (OTC BB: CPNE).

September is now in the rear view mirror, and it's time to turn reverse the order. We are now entering the period of time during which microcap stocks tend to trade great. It seems each year the "switch" turns on at a different time- two years ago it started right now. Last year is started in January.

Regardless, this is "Don't Say You Weren't Warned" - but it's the October version. Now, I am warning you it is time to be fully invested. This is our time of the year. Now is the time to beef up your ownership in stories you like. You will always make the most money in microcaps between now and May.

There is very recent evidence to support this argument. Forget the fact that oil and gold are getting clobbered and the market is moving up nicely at the same time. Forget that the DOW has finally, after five years of struggle, made a new all time high (isn't that what markets are supposed to do?).

Let's just look at the two most recent OTC Journal ideas. On September 18th I introduced Auriga Labs (OTC BB: ARGA) at $1.50. The stock traded over $2 yesterday, and is now sitting on a 23% gain. That's in a mere two weeks.

Two weekends ago I introduced PhotoChannel Networks (OTC BB: PHCHF) at $.19. Yesterday the stock traded to almost $.26, and is now holding up at about the $.23 level. That's a 21% gain at the current level in about 8 trading days.

Furthermore, OTC Journal #1 pick Commerce Planet (OTC BB: CPNE) is once again trading at a new multi month high of $1.60 plus- My September 25th BLOG stated it was a good technical buy at $1.20. If you don't own that stock I'm not doing a very good job convincing you the company is exploding. Even if I haven't done a good job, the way the stock is trading should have convinced you by now.

These aren't mega breakouts- yet. The best is yet to come. The next six months is the time make some real money. 

Earlier in September I informed everyone there would be three new OTC Journal ideas coming out in the near future. So far, with ARGA and PHCHF we have two legs of the three legged stool. Both have been unqualified winners so far.

This weekend I will be introducing the third leg of the three legged stool. Here's a hint- it's the only company on Planet Earth actually making a profit in facial recognition software. They are miles ahead of the crowd, and are doing real installations where there is a real need with revolutionary technology.  Check your inbox over the weekend. This one looks very exciting.

Subscribe

Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.

Go Here to view our compensation on every company we have ever covered, or visit the following web address:  http://www.otcjournal.com/disclaimer.html for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html for Trading Alerts.

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities  mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

From time to time MarketByte LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

The editor, members of the editor's family, and/or entities with which they are affiliated aside from MarketBtye LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter. Some of the companies featured in the OTC Journal pay a cash ESP fee to an affiliated technology company ranging from $2,000 to $5,000 per month for internet related technology services.

The Trustee of the MarketByte LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $140,0000 in Dutchess Private Equities II LP (“the Dutchess Limited Partnership”), a limited partnership in which the MarketByte Pension Plan is a limited partner. The Trustee of the MarketByte LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $190,0000 in the Longview Fund (“the Longview Limited Partnership”), both limited partnerships in which the MarketByte Pension Plan is a limited partner. No one associated with the MarketByte Pension Plan has any knowledge, information, or control as to any past, present, or future investment activities of the Dutchess Limited Partnership or the Longview Fund.  The Dutchess Limited Partnership is one of two hedge funds managed by Dutchess Advisors.  Dutchess Advisors and Longview periodically refers companies to MarketByte LLC for possible coverage by one of the MarketByte LLC publications, which publications include The OTCJournal.com Newsletter.  Dutchess Advisors or Longview may or may not own shares in the companies that it so refers to MarketByte. MarketByte has no information (outside of information readily accessible to the general public such as SEC filings) as to whether Dutchess Advisors or Longview owns any shares in the companies that it refers to MarketByte LLC.  The above relationships should be viewed as a potential and/or actual conflict of interest by shareholders and prospective shareholders of MarketByte LLC client companies. 

The profiles, critiques, and other editorial content of the OTCjournal.com may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN  SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN  CONSENT OF THE EDITORS OF OTCjournal.com.

We encourage our readers to invest carefully and read the investor information available at the web sites of  the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at  http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID:$subst('Recip.userid') Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.  MarketByte LLC's mailing address is 4653 Carmel Mtn Rd Suite 308 #402, San Diego, CA 92130.